BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 26723851)

  • 1. Farnesoid X receptor-dependent and -independent pathways mediate the transcriptional control of human fibroblast growth factor 19 by vitamin A.
    Jahn D; Sutor D; Dorbath D; Weiß J; Götze O; Schmitt J; Hermanns HM; Geier A
    Biochim Biophys Acta; 2016 Feb; 1859(2):381-92. PubMed ID: 26723851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho.
    Fu T; Kim YC; Byun S; Kim DH; Seok S; Suino-Powell K; Xu HE; Kemper B; Kemper JK
    Mol Endocrinol; 2016 Jan; 30(1):92-103. PubMed ID: 26505219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
    Zhou M; Luo J; Chen M; Yang H; Learned RM; DePaoli AM; Tian H; Ling L
    J Hepatol; 2017 Jun; 66(6):1182-1192. PubMed ID: 28189755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis.
    Byun S; Jung H; Chen J; Kim YC; Kim DH; Kong B; Guo G; Kemper B; Kemper JK
    J Biol Chem; 2019 May; 294(22):8732-8744. PubMed ID: 30996006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile Acids as Hormones: The FXR-FGF15/19 Pathway.
    Kliewer SA; Mangelsdorf DJ
    Dig Dis; 2015; 33(3):327-31. PubMed ID: 26045265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SREBP-2 negatively regulates FXR-dependent transcription of FGF19 in human intestinal cells.
    Miyata M; Hata T; Yamazoe Y; Yoshinari K
    Biochem Biophys Res Commun; 2014 Jan; 443(2):477-82. PubMed ID: 24321096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol.
    Bertolini A; van de Peppel IP; Doktorova-Demmin M; Bodewes FAJA; de Jonge H; Bijvelds M; Verkade HJ; Jonker JW
    Am J Physiol Gastrointest Liver Physiol; 2019 Mar; 316(3):G404-G411. PubMed ID: 30653340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the farnesoid X receptor induces hepatic expression and secretion of fibroblast growth factor 21.
    Cyphert HA; Ge X; Kohan AB; Salati LM; Zhang Y; Hillgartner FB
    J Biol Chem; 2012 Jul; 287(30):25123-38. PubMed ID: 22661717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Heterodimer Partner and Fibroblast Growth Factor 19 Inhibit Expression of NPC1L1 in Mouse Intestine and Cholesterol Absorption.
    Kim YC; Byun S; Seok S; Guo G; Xu HE; Kemper B; Kemper JK
    Gastroenterology; 2019 Mar; 156(4):1052-1065. PubMed ID: 30521806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation.
    Rau M; Stieger B; Monte MJ; Schmitt J; Jahn D; Frey-Wagner I; Raselli T; Marin JJ; Müllhaupt B; Rogler G; Geier A
    Inflamm Bowel Dis; 2016 Oct; 22(10):2382-9. PubMed ID: 27580383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis.
    Byun S; Kim DH; Ryerson D; Kim YC; Sun H; Kong B; Yau P; Guo G; Xu HE; Kemper B; Kemper JK
    Nat Commun; 2018 Jul; 9(1):2590. PubMed ID: 29968724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation.
    Degirolamo C; Modica S; Vacca M; Di Tullio G; Morgano A; D'Orazio A; Kannisto K; Parini P; Moschetta A
    Hepatology; 2015 Jan; 61(1):161-70. PubMed ID: 24954587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor.
    Gadaleta RM; Garcia-Irigoyen O; Cariello M; Scialpi N; Peres C; Vetrano S; Fiorino G; Danese S; Ko B; Luo J; Porru E; Roda A; Sabbà C; Moschetta A
    EBioMedicine; 2020 Apr; 54():102719. PubMed ID: 32259714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of multiple elements in FXR-mediated transcriptional activation of FGF19.
    Miyata M; Hata T; Yamakawa H; Kagawa T; Yoshinari K; Yamazoe Y
    J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):41-7. PubMed ID: 22561792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Regulation of FGF19 and FGF21 Expression by Cellular and Nutritional Stress.
    Shimizu M; Morimoto H; Maruyama R; Inoue J; Sato R
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(2):154-60. PubMed ID: 26052146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acid signal-induced phosphorylation of small heterodimer partner by protein kinase Cζ is critical for epigenomic regulation of liver metabolic genes.
    Seok S; Kanamaluru D; Xiao Z; Ryerson D; Choi SE; Suino-Powell K; Xu HE; Veenstra TD; Kemper JK
    J Biol Chem; 2013 Aug; 288(32):23252-63. PubMed ID: 23824184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice.
    Hartmann P; Hochrath K; Horvath A; Chen P; Seebauer CT; Llorente C; Wang L; Alnouti Y; Fouts DE; Stärkel P; Loomba R; Coulter S; Liddle C; Yu RT; Ling L; Rossi SJ; DePaoli AM; Downes M; Evans RM; Brenner DA; Schnabl B
    Hepatology; 2018 Jun; 67(6):2150-2166. PubMed ID: 29159825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental regulation of the intestinal FGF19 system in domestic pigs.
    Gavaldà-Navarro A; Pastor JJ; Mereu A; Villarroya F; Ipharraguerre IR
    Am J Physiol Gastrointest Liver Physiol; 2018 Jun; 314(6):G647-G654. PubMed ID: 29446652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gut-liver axis in hepatocarcinoma: a focus on the nuclear receptor FXR and the enterokine FGF19.
    Piglionica M; Cariello M; Moschetta A
    Curr Opin Pharmacol; 2018 Dec; 43():93-98. PubMed ID: 30223181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.